Manufacturing Partnership Recent manufacturing partnership with Rhythm Biosciences signals a channel to scale production of multiplex kits. This indicates a capacity for contract manufacturing, fill-finish, and potential co-development services that could be offered to new and existing customers.

Imaging Platform Growth The launch of the Q-View Imager Plus demonstrates demand for high resolution imaging and streamlined workflows. This creates cross-sell opportunities to academic labs, CROs, and diagnostic developers seeking integrated imaging with multiplex kits, plus service and training offerings.

Multiplex Disease Panels Quansys has demonstrated capability in multiplex serology, including SARS-CoV-2 4-plex assays. There is market potential to expand multiplex panels for infectious disease surveillance and biomarker discovery, appealing to public health labs, pharma R&D, and research institutions.

Data Analytics Edge With integrated Q-plex Imagers and Software, there is a pathway to offer data analysis services, software subscriptions, and workflow integration as a packaged solution. Target laboratories seeking end to end solutions may adopt bundled hardware, reagents, and analytics to improve consistency and turnaround time.

Channel Partnerships As a small, specialized player, Quansys can leverage partnerships with distributors, contract research organizations, and regional biotech ecosystems to scale reach. Propose channel partnerships, OEM arrangements, and regional sales aligned with immunoassay demand across labs and clinics.